Philip Bath, M.D., D.Sc., is Stroke Association Professor of Stroke Medicine, and Chair and Head of the Division of Clinical Neuroscience at the University of Nottingham. He is also a convener for the Neuroscience@Nottingham and Vascular Research multidisciplinary groups, and National Institute for Health Research (NIHR) Associate Director for Industry and Prevention in the Stroke Research Network. With 339 publications, he was the Stroke Association Keynote Lecturer in March 2015.

Clinically, he contributes to the NUH Stroke Service (in-patient and out-patient stroke care) and Hypertension Clinic. As an NIHR Senior Investigator, his main research interests cover the treatment of acute stroke (blood pressure lowering), prevention of stroke recurrence and cognitive impairment (antiplatelets, blood pressure, and lipid-lowering), and enhancement of recovery using stem cells. He uses preclinical studies, clinical trials (phase I to IV), and systematic reviews to address these questions.

Dr. Bath received his M.D. from King's College London, University of London, and his D.Sc. from the University of Nottingham.

John Volpi, M.D.,  is the Co-Director of the Eddy Scurlock Stroke Center at Houston Methodist and Associate Professor of Clinical Neurology at the Institute for Academic Medicine.  His research interests are in the management and prevention of ischemic stroke and the critical care of patients with neurological illnesses such as intracerebral hemorrhage, epilepsy, and nervous system infections.  His studies also involve the use of ultrasound in the evaluation of blood flow to the brain and the development of novel therapies for improving patient outcomes in stroke. 

Dr. Volpi received his M.D. from Baylor College of Medicine.

Dr. Thomas Devlin provides highly skilled care in the treatment of stroke and conditions of the nervous system and brain. Dr. Devlin is certified by the American Board of Neurology and Psychiatry with a Vascular Neurology Subspecialty and the American Board of Sleep Medicine. Internationally renowned, Dr. Devlin has been at the forefront of stroke research and innovation for more than twenty years. He is known as a major contributor to many of the medical breakthroughs in the modern-day diagnosis and treatment of stroke and currently serves as the co-director of the national neuroscience service line for CommonSpirit Health, CHI Memorial’s parent organization.

Dr. Kevin Sheth is a founding Director of the Yale Center for Brain & Mind Health and the Vice Chair for Clinical and Translational Research for the departments of Neurology. and Neurosurgery. He leads prevention efforts in neurologically vulnerable populations and works towards advancing therapies for acute brain injury such as stroke and brain hemorrhage. In pioneering the development of new strategies to treat brain swelling, his work has changed the fundamental approach to brain injury in the ICU and spurred the creation of new technologies in drug delivery and neuroimaging. Highly collaborative, interdisciplinary efforts from the lab have culminated in the first phase III trial to prevent brain swelling in stroke, the first phase III NIH funded prevention trial in brain hemorrhage, and the deployment of the first portable bedside MRI for brain injury in the world. His team at Yale has served as a national model for academic critical care neurology units. In recent years his group has also turned their attention to public health prevention efforts, focusing on cardiometabolic risk factors that can prevent decline in brain health resulting from stroke, dementia, and depression.

He is currently a principal investigator for two NIH neuroscience networks, StrokeNet, and SIREN. He is a multi-PI for four additional RO1/UO1 awards from the NIH. Dr. Sheth has served as PI or co-PI for 8 multicenter clinical trials in stroke. He is a winner of the prestigious Robert Siekert Award from the American Heart Association (AHA), the Derek Denny Brown Award from the American Neurological Association and an elected member of the American Society for Clinical Investigation (ASCI). Most recently, he was the recipient of the Stroke Research Mentorship Award from the American Heart Association. Dr. Sheth is the author of over 300 publications. His work has been showcased in The Washington Post, Wall Street Journal, Scientific American, NPR, and CNN.

Finally, Dr. Sheth has formed exciting partnerships with entrepreneurs, pharmaceutical companies, and medical device start-ups to bring forward highly innovative solutions. These efforts have resulted in extensive knowledge of FDA pathways, development of phase I-III drug programs, and implementation of new technology into the clinical workspace. The principal theme of his efforts are towards collaboration and an improved understanding of neurological disease.